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1. Introduction 
During past decades the relationship between dentistry and internal medicine has been 
intensely debated. Current evidence suggests that inflammation due to periodontal 
infections may not be limited to the immediate oral environment but can have systemic 
effects. Clinical, epidemiological and molecular studies have demonstrated significant 
association between periodontitis and various diseases, such as coronary heart disease, 
atherosclerosis, bacterial pneumonia, diabetes mellitus and low birth weight. Individuals 
with periodontal infections have elevated concentrations of circulating inflammatory 
markers, disease severity directly correlates with serum concentrations of inflammatory 
markers, and treatment of periodontal infection can lower markers of systemic 
inflammatory dysfunction within 2–6 months. 
Various hypotheses, including common susceptibility, systemic inflammation, direct 
bacterial infection and cross-reactivity, or molecular mimicry, between bacterial antigens 
and self-antigens, have been postulated to explain these relationships. In this scenario, the 
association of periodontal disease with systemic diseases has set the stage for introducing 
the concept of periodontal medicine. 
At present it is generally agreed on that oral status is connected with systemic health, since 
poor oral health may occur concomitantly with more serious underlying diseases and/or it 
may predispose to other systemic diseases. The pioneering approach of periodontal 
medicine has helped to renew attention on the theory of focal infection and the deepening of 
the relationship between chronic periodontitis and systemic health. 
In recent years, chronic periodontitis has been proposed as a risk factor for pancreatic 
cancer. Chronic periodontitis might promote pancreatic carcinogenesis, by means of 
systemic inflammation, or alternatively, through increased production of carcinogens, 
namely nitrosamines. 
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The aim of the present study was to investigate pancreatic tissue for the potential presence 
of periodontopathogenic microorganisms.  
2. Periodontal diseases 
Periodontal diseases are a group of bacterial inflammatory diseases of the supporting tissues 
of the teeth (gingiva, periodontal ligament, cementum and alveolar bone). Periodontal diseases 
include two general conditions based on whether there is attachment or bone loss: gingivitis 
and periodontitis. Gingivitis is considered a reversible form of the disease, and generally 
involves inflammation of the gingival tissues without loss of connective tissue attachment. 
Gingivitis is the most common and prevalent form of periodontal disease among children and 
adolescents. The incidence and severity increase from childhood to adolescence, reaching a 
peak prevalence of 80% at 11-13 years of age. The progression from gingivitis to periodontitis 
is characterized by periodontal pocket development, which favours further plaque 
accumulation and a shift in its qualitative composition. Thereafter, as the severity of gingivitis 
decreases, chronic periodontitis measured by attachment loss becomes dominant and 
continues to increase in severity with age. Periodontitis is a chronic infection involving 
destruction of tooth-supporting tissues, including the periodontal ligament and alveolar socket 
support of the teeth. Periodontal disease can affect one tooth or many teeth and, if left 
untreated, can lead to tooth loss, particularly in adults. It is the most common dental condition 
in adults, and is also one of the most common chronic inflammatory diseases affecting a 
majority of the population throughout the world. Some of the clinical signs include bleeding 
on probing, deep pockets, recession and tooth mobility. Progressive changes from healthy 
gums to necrotizing periodontitis are given in Figures 1 to 5. 
 
 
Fig. 1. Healthy gums 
 
 
Fig. 2. Gingivitis 
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2.1 Classification of periodontal diseases 
2.1.1 Chronic periodontitis 
Chronic periodontitis is the most common form of periodontitis in adults, but can occur at 
any age. Progression of attachment loss usually occurs slowly, but periods of exacerbation 
with rapid progression, or periods of remission can occur. The rate of disease progression 
may be influenced by local (subgingivally placed fillings or crowns, tooth caries…) and/or 
systemic conditions (diabetes mellitus, pregnancy, puberty, leukemia…) that alter the 
normal host response to bacterial plaque. The severity of disease can be described as slight, 
moderate, or severe, based on the level of destruction.  
 
 
Fig. 3. Gingivitis 
 
 
Fig. 4. Periodontitis 
2.1.2 Aggressive periodontitis 
Aggressive periodontitis (previously Juvenile Periodontitis) is characterized by rapid 
attachment loss and bone destruction in the absence of significant accumulations of plaque 
and calculus. (Tonetti&Mombelly, 1999) This form of periodontitis usually affects young 
individuals, often during puberty, from 10-30 years of age, with genetic predisposition. The 
bacteria most often associated with aggressive periodontitis is Aggregatibacter 
actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans). Aggressive 
periodontitis can occur as localized or generalized forms. The localized form usually affects 
first molar and incisor sites. The generalized form usually involves at least three teeth other 
than first molars and incisors.  
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2.1.3 Periodontitis as a manifestation of systemic diseases 
Periodontitis as a manifestation of systemic diseases may be associated with diabetes, 
several hematological (acquired, familial, and cyclic neutropenias, leukemias) and genetic 
disorders (Down’s syndrome, certain types of Ehlers-Danlos syndrome, Papillon-Lefevre 
syndrome, Cohen syndrome and hypophosphatasia). The mechanisms by which all of these 
disorders affect the health of periodontium are not fully understood, but it is speculated that 
these diseases can alter host defense mechanisms and upregulate inflammatory responses, 
resulting in progressive periodontal destruction.  
2.1.4 Necrotizing periodontal diseases 
Necrotizing periodontal diseases (necrotizing gingivitis, necrotizing periodontitis and 
necrotizing stomatitis) are the most severe inflammatory periodontal disorders caused by 
plaque bacteria. These lesions are commonly observed in individuals with systemic 
conditions such HIV infection, malnutrition and immunosuppression. Clinical 
characteristics of necrotizing periodontal diseases may include but are not limited to 
ulcerated and necrotic papillary and marginal gingiva covered by a yellowish and grayish 
slough or pseudomembrane, blunting and cratering of papillae, bleeding on provocation or 
spontaneous bleeding, pain, and fetid breath. These diseases may be accompanied by fever, 
malaise, and lymphadenopathy, although these characteristics are not consistent.  
 
 
Fig. 5. Necrotizing periodontitis 
These diseases appear to have multiple etiologies, microbial and immunological being the 
two most studied. The primary microbial factor contributing to disease is a shift in the 
content of the oral microflora, while the primary immunological factor is the destructive 
host inflammatory response.  
2.2 Microbial etiology of periodontal disease  
As many as 700 different species of bacteria that colonize the oral cavity can affect the 
delicate balance of host-bacterial interactions leading to disease. Periodontal infection is 
initiated by specific invasive oral pathogens that colonize dental plaque biofilms on the 
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tooth root surface. No one knows how many bacterial species, ribotypes, and serotypes 
coexist in the dental plaque, but the number is very large. With the advent of PCR 
technologies, many new uncultivable species are being identified. 
The onset and progression of periodontal disease is attributed to the presence of elevated 
levels of a consortium of pathogenic bacteria within the gingival crevice. The plaque is 
divided into two distinct types based on the relationship of the plaque to the gingival 
margin, i.e., supragingival plaque and subgingival plaque. The supragingival plaque is 
dominated by facultative Streptococcus and Actinomyces species, whereas the subgingival 
plaque harbors an anaerobic gram-negative flora dominated by uncultivable spirochetal 
species. It is this gram-negative flora that has been associated with periodontal disease. 
Since many of its members derive some of their nutrients from the gingival crevicular fluid, 
a tissue transudate that seeps into the periodontal area, it is possible that their overgrowth is 
a result of the inflammatory process (Loe et al., 1965). 
The disease is a chronic low grade infection involving mainly Gram-negative anaerobic 
bacteria. There is a clear evidence for the pathogenic role of Aggregatibacter 
actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia in periodontal 
disease development and a reasonably strong evidence exists for the pathogenic role in 
certain forms of periodontal disease of some other microorganisms such as Prevotella 
intermedia, Fusobacterium nucleatum, Campylobacter rectus, Eikenella corrodens etc (Brajovic et 
al., 2010; Milicevic et al, 2008). A number of gram-negative rods and spirochetes are putative 
periodontal pathogens, but these organisms may also be present, although in smaller 
concentrations, in healthy patients.  
Although the plaque is essential for the initiation of periodontal diseases, the majority of the 
destructive processes associated with these diseases are due to an excessive host response to 
the bacterial challenge. Periodontal bacteria possess a plethora of virulence factors that, 
upon interaction with host cells, induce the production of inflammatory mediators at the 
gingival level. 
2.3 Host inflammatory response to bacterial challenge 
The fundamental question in regard to periodontal pathology is whether the host is 
responding to the nonspecific overgrowth of bacteria on the tooth surfaces (inflammatory 
disease) or to the overgrowth of a limited number of species which produce biologically 
active molecules that are particularly proinflammatory or antigenic (infection). 
There is a distinction between the way the host responds to the supragingival plaque and its 
response to the subgingival plaque. The response to the supragingival plaque has been 
thoroughly studied in the experimental gingivitis model described below, whereas the 
response to the subgingival plaque remains under investigation. Does the host respond to 
the subgingival plaque as if it were an overgrowth of a bacterial community in which many 
members produce substances, such as LPS, that are particularly bioactive if they enter the 
gingival tissue? Or does it respond to a plaque in which certain members produce more 
biologically active molecules, such as butyric acid (Niederman al., 1997) or hydrogen sulfide 
(Ratcliff&Johnson, 1999), per cell or possess unique proteases, such as are found in P. 
gingivalis and Treponema denticola, which can degrade host molecules, creating a 
proinflammatory effect (Kuramitsu, 1998)? In either case, although bacteria are involved, it 
is not the scenario of a typical infection, as the offending bacteria generally remain outside 
the body, attached to the tooth. 
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Fig. 6. A) Histology of normal gingiva; B) Accumulation of Gram positive and Gram 
negative bacteria and bacterial toxins; C) Basement membrane and tissue destruction 
leading to epithelial ulcerations. 
In periodontal disease the inflammatory response causes tissue resistance to bacterial 
invasion but also provides mechanisms that contribute to tissue damage. Acute 
inflammatory cells, such as mast cells, macrophages, Langerhans cells, and 
polymorphonuclear leukocytes, combine their action to form a potent antibacterial defense 
mechanism. However the initial signs of gingival inflammation (swelling, redness, bleeding 
on probing) are nothing but the tissue-destructive aspects of the activity of these cells. 
Neutrophils function to control the bacterial assault by phagocytosis but also secrete matrix 
metalloproteinases (MMP), which are the agents responsible for collagen loss in the tissues. 
These latent collagenolytic enzymes can be converted to active forms by proteases and 
reactive oxygen species in the inflammatory environment, giving rise to elevated levels of 
interstitial collagenase in the inflammed gingival tissue. The resulting attachment loss 
deepens the sulcus, or depression, formed where the gingival tissues contact the tooth 
surface, thereby creating the periodontal pocket. By definition, this loss of attachment 
converts gingivitis to periodontitis. The depth of the pocket reflects an inflammatory 
response that causes both the swelling of the gingival tissues at the top of the pocket and the 
loss of collagen attachment of the tooth to the alveolar bone at the bottom of the pocket. 
Good oral hygiene can reduce the inflammatory swelling, but the attachment loss and 
accompanying bone loss is thought to be irreversible. In established periodontal disease, 
there is also a chronic inflammatory change, with B cells and T cells adding to the 
antibacterial spectrum. These cells also have capacity to release cytokines, which may 
induce the synthesis of arachidonate metabolites (especially PGE2), and to stimulate 
macrophages and osteoclasts to release hydrolases and collagenases, which are responsible 
for loss of collagen and bone. The interaction of bacterial antigens with peripheral dendritic 
cells leads to the generation of systemic antibody, whereas interaction with local B cells 
leads to production of local antibody. Antibody specific to many of the periodontal 
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microorganisms is essential for phagocytosis. Complement components also may contribute 
to efficient bacterial phagocytosis. The production of interleukin-1ǃ (IL-1ǃ), tumor necrosis 
factor alpha (TNF-ǂ), and prostaglandin E2 (PGE2) in response to bacterial 
lipopolysaccharides (LPS) leads to bone resorption through osteoclast activation, 
proliferation, and differentiation. Each patient with dental plaque has a complex balance 
between these protective and damaging scenarios that results either in a slowly progressive 
loss of attachment (periodontitis) or in a restriction of tissue inflammation to the peripheral 
tissues (gingivitis).    
2.4 Treatment of periodontal disease  
Various treatment modalities, such as the traditional debridement procedures (scaling and 
root planning), surgery (Kwan et al., 1998; Lekovic et al., 1997, 1998a, 1998b, 2001a, 2001b, 
2003, 2005; Camargo et al., 1998, 2000, 2002, 2005) and various antimicrobial regimens were 
introduced for the treatment of periodontal disease. 
Traditional treatments reflect the premise that periodontal disease is due to the nonspecific 
overgrowth of any and all bacteria on the tooth surfaces and that the magnitude of the 
bacterial overgrowth on the teeth can be controlled by professional cleaning of the teeth at 
regular intervals. If these accumulations are not removed, various bacterial by-products and 
their cellular components such as LPS, antigens, or enzymes can provoke an inflammatory 
response in the gingival tissue. Undisturbed plaques often become calcified, forming dental 
calculus or tartar, which, if formed below the gingival margin, is often difficult to remove 
from the root surfaces without some form of surgical access. 
This type of periodontal treatment which is considered to be the standard treatment, is 
based on the premise that if the bacterial overgrowth in dental plaque can be continuously 
suppressed by mechanical debridement, gingival and periodontal health will be maintained. 
It is the basis of the “plaque control” programs of organized dentistry and dentifrice 
manufacturers; as a public health effort, this approach has been very successful. 
3. Oral-systemic relationship 
In the last decade, the possible association between oral and systemic health has been 
highlighted in numerous reports. Apart from the seeding infection as a direct consequence 
of transient bacteraemia, such oral-systemic interactions and outcomes could be due to 
other, indirect reasons, such as metastatic inflammation as a result of circulating 
macromolecular complexes and/or metastatic injury due to soluble toxins and bacterial 
lipopolysaccharide. It has become increasingly clear that the oral cavity can act as the site of 
origin for dissemination of pathogenic organisms to distant body sites, especially in 
immunocompromised hosts such as patients suffering from malignancies, diabetes, or 
rheumatoid arthritis or having corticosteroid or other immunosuppressive treatment. A 
number of epidemiological studies have suggested that oral infection, especially marginal 
and apical periodontitis, may be a risk factor for systemic diseases. 
3.1 Transient bacteraemia 
In common inflammatory conditions such as gingivitis and chronic periodontitis, which are 
precipitated by the buildup of plaque biofilms, the periodontal vasculature proliferates and 
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dilates, providing an even greater surface area that facilitates the entry of microorganisms 
into the bloodstream. Often, these bacteraemias are short-lived and transient, with the 
highest intensity limited to the first 30 min after a trigger episode. On occasions, this may 
lead to seeding of microorganisms in different target organs, resulting in subclinical, acute, 
or chronic infections. Yet there are a number of other organs and body sites that may be 
affected by focal bacteremic spread from the oral cavity. Based on the current evidence, it is 
likely that bacteria may enter into the bloodstream from oral niches through a number of 
mechanisms and a variety of portals. First, and most commonly, when there is tissue trauma 
induced by procedures such as periodontal probing, scaling, instrumentation beyond the 
root apex, and tooth extractions, a breakage in capillaries and other small blood vessels that 
are located in the vicinity of the plaque biofilms may lead to spillage of bacteria into the 
systemic circulation. As stated above, dissemination of oral microorganisms into the 
bloodstream is common, and less than 1 minute after an oral procedure, organisms from the 
infected site may have reached the heart, lungs, and peripheral blood capillary system. 
There are more than 1013 microbes on all surfaces of the body, yet the underlying tissues and 
the bloodstream are usually sterile. In the oral cavity there are several barriers to bacterial 
penetration from dental plaque into the tissue: a physical barrier composed of the surface 
epithelium; defensins, which are host-derived peptide antibiotics, in the oral mucosal 
epithelium; an electrical barrier that reflects the difference between the host cell and the 
microbial layer; an immunological barrier of antibody-forming cells; and the 
reticuloendothelial system (phagocyte barrier). Under normal circumstances, these barrier 
systems work together to inhibit and eliminate penetrating bacteria. When this state of 
equilibrium is disturbed by an overt breach in the physical system (e.g., trauma), the 
electrical system (i.e., hypoxia), or immunological barriers (e.g., through neutropenia, AIDS, 
or immunosuppressant therapy), microorganisms can propagate and cause both acute and 
chronic infections with increased frequency and severity. With normal oral health and 
dental care, only small numbers of mostly facultative bacterial species gain access to the 
bloodstream. However, with poor oral hygiene, the numbers of bacteria colonizing the teeth, 
especially supragingivally, could increase 2- to 10-fold and thus possibly introduce more 
bacteria into tissue and the bloodstream, leading to an increase in the prevalence and 
magnitude of bacteraemia. 
Obviously, a higher microbial load would facilitate such dissemination, as it is known that 
individuals with poor oral hygiene are at a higher risk of developing bacteraemias during 
oral manipulative procedures. Innate microbial factors may play a role in the latter 
phenomenon, as only a few species are detected in experimental bacteraemias despite the 
multitude of diverse bacteria residing within the periodontal biofilm. Species that are 
commonly found in the bloodstream have virulence attributes that could be linked to 
vascular invasion. Of particular note are attributes such as endothelial adhesion of 
Streptococcus spp., degradation of intercellular matrices by Porphyromonas gingivalis, and 
impedance of phagocytic activity by Aggregatibacter actinomycetemcomitans and Fusobacterium 
nucleatum. As opposed to the more than 700 bacterial species that inhabit the oral cavity, 
relatively fewer species have been isolated from blood cultures for odontogenic 
bacteraemias. Phylogenetic studies of the oral microbiome have shown that a large 
proportion of the oral bacteria comprise the genus Streptococcus (Van Dyke et al., 1982.). In a 
number of controlled clinical trials, streptococci were the predominant organisms isolated, 
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ranging from 40 to 65% of isolates. The highest incidence of bacteraemia results from tooth 
extractions. Periodontal manipulations are also shown to produce a long-lasting (30 min) 
bacteraemia. This is probably a reflection of the bacterial load and tissue trauma or 
associated inflammation at these niches. Other oral procedures are not as significant, at least 
for individuals with healthy oral cavities. Routine oral hygiene measures such as brushing 
or flossing are unlikely to cause a significant degree of bacteraemia, but sporadic cleaning 
after accumulation of a heavy plaque load should be considered a potential risk factor for a 
bacteremic state. 
3.2 Mechanisms linking oral infection to secondary nonoral diseases 
Three mechanisms or pathways linking oral infections to secondary systemic effects have 
been proposed. These are metastatic spread of infection from the oral cavity as a result of 
transient bacteraemia, metastatic injury from the effects of circulating oral microbial toxins, 
and metastatic inflammation caused by immunological injury induced by oral 
microorganisms. 
3.2.1 Metastatic infection 
As previously discussed, oral infections and dental procedures can cause transient 
bacteraemia. The microorganisms that gain entrance to the blood and circulate throughout 
the body are usually eliminated by the reticuloendothelial system within minutes 
(transient bacteraemia) and as a rule lead to no other clinical symptoms than possibly a 
slight increase in body temperature. However, if the disseminated microorganisms find 
favorable conditions, they may settle at a given site and, after a certain time lag, start to 
multiply. 
3.2.2 Metastatic injury 
Some gram-positive and gram-negative bacteria have the ability to produce diffusible 
proteins, or exotoxins, which include cytolytic enzymes and dimeric toxins. The exotoxins 
have specific pharmacological actions and are considered the most powerful and lethal 
poisons known (51). Conversely, endotoxins are part of the outer membranes released after 
cell death. Endotoxin is compositionally a lipopolysaccharide (LPS) that, when introduced 
into the host, gives rise to a large number of pathological manifestations. LPS is 
continuously shed from periodontal gram-negative rods during their growth in vivo. 
3.2.3 Metastatic inflammation 
Soluble antigen may enter the bloodstream, react with circulating specific antibody, and 
form a macromolecular complex. These immunocomplexes may give rise to a variety of 
acute and chronic inflammatory reactions at the sites of deposition. 
4. Periodontitis affects susceptibility to systemic disease 
In a recent review article, Page proposed that periodontitis may affect the host’s 
susceptibility to systemic disease in three ways: by shared risk factors, by subgingival 
biofilms acting as reservoirs of gram-negative bacteria, and through the periodontium 
acting as a reservoir of inflammatory mediators. 
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4.1 Shared risk factors 
Factors that place individuals at high risk for periodontitis may also place them at high risk 
for systemic diseases such as cardiovascular disease. Among the environmental risk factors 
and indicators shared by periodontitis and systemic diseases, such as cardiovascular 
disease, are tobacco smoking, stress, aging, race or ethnicity, and male gender. Studies 
demonstrating genetic factors shared by periodontitis, cardiovascular disease, preterm 
labor, and osteoporosis have not yet been performed but may be fruitful. 
4.2 Subgingival biofilms 
Subgingival biofilms constitute an enormous and continuing bacterial load. They present 
continually renewing reservoirs of LPS and other gram-negative bacteria with ready access 
to the periodontal tissues and the circulation. Systemic challenge with gram-negative 
bacteria or LPS induces major vascular responses, including an inflammatory cell infiltrate 
in the vessel walls, vascular smooth muscle proliferation, vascular fatty degeneration, and 
intravascular coagulation. LPS upregulates expression of endothelial cell adhesion 
molecules and secretion of interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-a), and 
thromboxane, which results in platelet aggregation and adhesion, formation of lipidladen 
foam cells, and deposits of cholesterol and cholesterol esters. 
4.3 Periodontium as cytokine reservoir 
The proinflammatory cytokines TNF-a, IL-1b, and gamma interferon as well as 
prostaglandin E2 (PGE2) reach high tissue concentrations in periodontitis. The 
periodontium can therefore serve as a renewing reservoir for spillover of these mediators, 
which can enter the circulation and induce and perpetuate systemic effects. IL-1b favors 
coagulation and thrombosis and retards fibrinolysis. IL-1, TNF-a, and thromboxane can 
cause platelet aggregation and adhesion, formation of lipidladen foam cells, and deposition 
of cholesterol. These same mediators emanating from the diseased periodontium may also 
account for preterm labor and low-birth-weight infants (Page,  1998). 
5. Cardiovascular disease 
Cardiovascular disease and periodontal disease are both chronic inflammatory diseases. 
Numerous cross-sectional and longitudinal epidemiological studies have provided evidence 
that there is an association between periodontitis and elevated risk for cardiovascular 
disease. A number of systematic reviews and meta-analyses have described the relationship 
between periodontal infection and cardiovascular disease, and have suggested that 
periodontitis may contribute to cardiovascular disease and stroke in susceptible subjects. 
It is well accepted that hyperlipidemia is a risk factor for coronary heart disease. Recent 
studies have shown an association between periodontitis and elevated atherogenic lipid 
fraction levels and ⁄ or decreased anti-atherogenic lipid fraction levels. Most of these were 
cross-sectional studies, and it is still unclear whether there is a causal relationship between 
periodontitis and hyperlipidemia. Improvement of serum lipid profiles after periodontal 
treatment may indicate a causal relationship between periodontitis and hyperlipidemia, and 
may suggest the possibility of reducing the risk of coronary heart disease by effective 
periodontal intervention. 
C-reactive protein is an important marker for systemic inflammation, and has been 
consistently found to be elevated in patients with coronary syndromes. Recently, evidence 
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has accumulated demonstrating the association between periodontitis and C-reactive 
protein. The serum C-reactive protein concentration is increased in systemically healthy 
subjects with periodontitis. Numerous studies indicate that periodontal intervention 
therapy may decrease the C-reactive protein-associated cardiovascular disease risk. 
Many cytokines play a role in the pathogenesis of both coronary heart disease and 
periodontitis. These include interleukin-1, interleukin-6, interleukin-8, tumor necrosis factor-a, 
intercellular adhesion molecule-1 (ICAM-1), P-selectin and E-selectin. Some intervention 
studies have indicated that periodontal therapy can reduce the levels of these pro-inflammory 
cytokines, and thus periodontal treatment may lower the cardiovascular disease risk. 
Numerous studies of different design and rigor have provided statistical evidence for an 
association between periodontal disease and cardiovascular disease, raising the possibility 
that periodontal disease is a risk factor for cardiovascular disease. There are several 
proposed mechanisms (Fig. 1) by which periodontal disease may trigger pathways leading 
to cardiovascular disease through direct and indirect effects of oral bacteria. First, evidence 
indicates that oral bacteria such as Streptococcus sanguis and Porphyromonas gingivalis induce 
platelet aggregation, which leads to thrombus formation. These organisms have a collagen-
like molecule, the platelet aggregation- associated protein, on their surface. Furthermore, 
one or more periodontal pathogens have been found in 42% of the atheromas studied in 
patients with severe periodontal disease (Zambon, 1998). The second factor in this process 
could be an exaggerated host response to a given microbial or LPS challenge, as reflected in 
the release of high levels of proinflammatory mediators such as PGE2, TNF-a, and IL-1b. 
These mediators have been related to interindividual differences in the T-cell repertoire and 
the secretory capacity of monocytic cells. Typically, peripheral blood monocytes from these 
individuals with the hyperinflammatory monocyte phenotype secrete 3- to 10-fold-greater 
amounts of these mediators in response to LPS than those from normal monocyte 
phenotype individuals. Patients with certain forms of periodontal disease, such as early-
onset periodontitis and refractory periodontitis, possess a hyperinflammatory monocyte 
phenotype. A third mechanism possibly involves the relationship between bacterial and 
inflammatory products of periodontitis and cardiovascular disease. LPS from periodontal 
organisms being transferred to the serum as a result of bacteraemias or bacterial invasion 
may have a direct effect on endothelia so that atherosclerosis is promoted (Pesonen et al., 
1981). LPS may also elicit recruitment of inflammatory cells into major blood vessels and 
stimulate proliferation of vascular smooth muscle, vascular fatty degeneration, intravascular 
coagulation, and blood platelet function. These changes are the result of the action of 
various biologic mediators, such as PGs, ILs, and TNF-a on vascular endothelium and 
smooth muscle. Fibrinogen and WBC count increases noted in periodontitis patients may be 
a secondary effect of the above mechanisms or a constitutive feature of those at risk for both 
cardiovascular disease and periodontitis (Kweider et al., 1993).  
If so, periodontal disease, because it is both preventable and treatable, becomes a modifiable 
risk factor for cardiovascular disease. However, if periodontal disease is primarily due to the 
overgrowth of bacteria in the dental plaque, all individuals would need preventive 
treatment, since all individuals form dental plaque. 
5.1 Atherosclerosis 
Atherosclerosis has been defined as a progressive disease process that involves large- to 
medium-sized muscular and large elastic arteries. The advanced lesion is the atheroma, 
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which consists of elevated focal intimal plaques with a necrotic central core containing lysed 
cells, cholesterol ester crystals, lipid-laden foam cells, and surface plasma proteins, 
including fibrin and fibrinogen. In the last few years there were an increasing number of 
reports dealing with the possible relationship between atherosclerosis and periodontitis, as 
well as between chronic coronary heart disease and periodontitis (Fien et al., 2005; Ford et 
al., 2006; Pucar et al., 2007; Spahr et al., 2006). Arteries have been thoroughly explored for 
the presence of periodontopathogens and a variety of oral microorganisms have been found 
lodged in arterial walls.  
 
 
Fig. 7. Coronary artery with stable atheroma. Inflammation and necrosis have replaced the 
smooth muscle but there is a dense layer of collagen next to lumen (arrows) 
 
 
Fig. 8. Circulating oral bacteria have peptides that cause platelet aggregation (arrows) 
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There are sufficient data to consider that A.actimomycetamcomitans, P. gingivalis and P. 
intermedia have the ability to invade host cells including epithelium and endothelium 
evading the neutrophil clearance; in this way periodontal pathogens can penetrate the 
epithelial barrier of the periodontal tissues and get systemic spreading through the blood 
stream. By this dynamic, periodontal pathogens can infect directly the vascular 
endothelium, and atherosclerotic plaques, causing inflammation and plaque instability up to 
an acute myocardial ischemia. Moreover, periodontal pathogens produce a variety of 
virulence factors (e.g. adhesions, portliness, haemolysins, membrane vesicles and LPS) that 
have deleterious effects on vascular system, resulting in platelet aggregation and adhesion, 
formation of lipid-laden foam cells and deposits of cholesterol, all factors contributing to the 
formation of atheroma. 
Endothelial dysfunction is a fundamental step in the development of atherosclerosis, and 
can be measured by several methods, including flow-mediated dilatation of the brachial 
artery. Endothelial dysfunction as determined by measurement of brachial flow-mediated 
dilatation is considered to be a good predictor of cardiovascular outcomes (Roquer et al., 
2009). 
Periodontal disease is associated with endothelial dysfunction as measured by brachial 
flow-mediated dilatation. Endothelial function has been reported to be significantly lower in 
patients with periodontitis than in control subjects. In addition, endothelial dysfunction in 
hypertensive patients with periodontitis is more severe compared to hypertensive patients 
without periodontitis (Higashi et al., 2009). Recently, endothelial function was evaluated in 
healthy and periodontitis patients with coronary artery disease (Higashi et al., 2008). The 
results showed that endothelial function was significantly lower in the periodontitis group 
with coronary artery disease than in the nonperiodontitis group with coronary artery 
disease. These results suggest that periodontitis is a contributor to endothelial dysfunction, 
and hence could increase the risk of cardiovascular disease. Based on current evidence, 
periodontal therapy can improve endothelial dysfunction in periodontitis patients whether 
they are systemically healthy or have hypertension. This further confirms the causal 
association between periodontitis and endothelial dysfunction. As endothelial dysfunction 
is associated with an adverse prognosis for atherosclerosis and cardiovascular disease, 
periodontal intervention therapy may bring benefits to patients with periodontitis by 
improving endothelial function, thus reducing the risk of cardiovascular disease. However, 
this requires further study. 
6. Diabetes mellitus  
Recent findings indicate that oral health may influence systemic health, and that this may be 
a bi-directional relationship for some conditions. This is particularly true for the relationship 
between periodontal disease and diabetes mellitus. The inter-relationship between 
periodontal disease and diabetes mellitus provides an example of a cyclic association,  
whereby a systemic disease predisposes the individual to oral infections, and, once the oral 
infection is established, it exacerbates the systemic disease. 
The inflammatory response in the periodontal tissues in response to challenge by dental 
biofilm is complex and involves networks of cytokines functioning in synergy. The 
inflammatory response is characterized by localized production of various inflammatory 
markers and enzymes, such as C-reactive proteins, cytokines (interleukin-1b, interleukin- 6, 
tumor necrosis factor ǂ), prostanoids (prostaglandin E2) and matrix metalloproteinases. 
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These increased secretions of inflammatory cytokines contribute to bone loss in 
periodontitis. The balance between the protective host factors and microbial challenge is 
greatly influenced by environmental and genetic factors that have an impact on the 
immuno-inflammatory response of the host. Alterations in immunologically active 
molecules as a result of diabetes may alter the levels of cytokines in the periodontium, 
which accelerates progression of the disease. This is the scientific basis for the increased 
susceptibility to periodontal disease seen in diabetics. 
Patients with diabetes exhibited greater periodontal breakdown in response to dental 
biofilm; however, this depended on the degree of glycemic control (Arrieta-Blanco et al., 
2003; Bastard et al., 2006). The highest levels of gingivitis were seen in diabetic patients with 
poor glycemic control (Mealey, 2006). Clinical and epidemiological studies have reported a 
higher prevalence and increased severity of periodontal disease in diabetic patients 
compared with non-diabetic controls (Ciancola et al., 1982; Collin et al., 1998; Safkan-
Seppala et at., 1992). Studies have shown that diabetes carries a threefold increased risk of 
periodontitis compared to non-diabetic individuals (Lo¨e et al., 1978; Sclossman et al., 1990). 
Alveolar bone loss is enhanced in these individuals, resulting in a more persistent 
inflammatory response in diabetics. This leads to greater attachment loss and impaired 
formation of new bone (Liu et al., 2006). In addition, Lo¨e (Lo¨e, 1993) described 
periodontitis as the 6th complication of diabetes, together with retinopathy, nephropathy, 
neuropathy, macrovascular diseases and altered wound healing. The complications of 
diabetes are related to long-term elevation of blood glucose concentrations 
(hyperglycaemia) that results in the formation of advanced glycation end-products (AGEs). 
The accumulation of AGEs increases the intensity of the immune-inflammatory response to 
different pathogens, because inflammatory cells such as monocytes and macrophages have 
receptors for AGEs with consequent increased production of IL-1ǃ and TNF-ǂ. The AGEs-
enriched gingival tissue has greater vascular permeability, greater breakdown of collagen 
fibers and accelerated destruction of both non-mineralized connective tissue and bone 
occurs. Diabetes can also cause damage of neutrophil adhesion, chemotaxis and 
phagocytosis, making patients more susceptible to periodontal destruction. The effects of 
the hyperglycemic state include the inhibition of osteoblastic proliferation and collagen 
production. Several studies indicated that diabetes is associated with an increased 
prevalence, extent and severity of chronic periodontitis. Other studies have suggested that 
the presence of periodontal infection may be linked to poor metabolic control of diabetes 
(Southerland et al., 2005). Treatment of periodontal disease can alter glycemic control, and 
early intervention and treatment of periodontitis may help to prevent the long-term 
complications of diabetes, thereby having an impact on mortality. 
7. Bacterial pneumonia  
Pneumonia is an infection of pulmonary parenchyma caused by a wide variety of infectious 
agents, including bacteria, fungi, parasites, and viruses. Pneumonia can be a life-threatening 
infection, especially in the old and immunocompromised patient, and is a significant cause 
of morbidity and mortality in patients of all ages. Most commonly, bacterial pneumonia 
results from aspiration of oropharyngeal flora into the lower respiratory tract, failure of host 
defense mechanisms to eliminate them, multiplication of the microorganisms, and 
subsequent tissue destruction. It is likely that most pathogens first colonize the surfaces of 
the oral cavity or pharyngeal mucosa before aspiration. These pathogens can colonize from 
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an exogenous source or emerge following overgrowth of the normal oral flora after 
antibiotic treatment. Common potential respiratory pathogens (PRPs) such as Streptococcus 
pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae can colonize the oropharynx 
and be aspirated into the lower airways. Other species thought to comprise the normal oral 
flora, including A. actinomycetemcomitans and anaerobes such as P. gingivalis and 
Fusobacterium species, can also be aspirated into the lower airways and cause pneumonia. 
Pneumonia can result from infection by anaerobic bacteria. Dental plaque would seem to be 
a logical source of these bacteria, especially in patients with periodontal disease. Such 
patients harbor a large number of subgingival bacteria, particularly anaerobic species. 
Among the oral bacterial species implicated in pneumonia are A. actinomycetemcomitans, 
Actinomyces israelii, Capnocytophaga spp., Eikenella corrodens, Prevotella intermedia, and 
Streptococcus constellatus. A study has shown that individuals with respiratory disease have 
significantly higher oral hygiene index scores than subjects without respiratory disease.  
8. Low birth weight  
Pregnancy can influence gingival health. Changes in hormone levels during pregnancy 
promote an inflammation termed pregnancy gingivitis. This type of gingivitis may occur 
without changes in plaque levels. Oral contraceptives may also produce changes in gingival 
health. Some birth control pill users have a high gingival inflammation level but a low 
plaque level. Birth control pills may cause changes such as alteration of the 
microvasculature, gingival permeability, and increased synthesis of estrogen. 
Oral infections also seem to increase the risk for or contribute to low birth weight in 
newborns. Low birth weight, defined as a birth weight of <2,500 g, is a major public health 
problem in both developed and developing countries. As a remote gram-negative infection, 
periodontal disease may have the potential to affect pregnancy outcome. During pregnancy, 
the ratio of anaerobic gram-negative bacterial species to aerobic species increases in dental 
plaque in the second trimester. The gram-negative bacteria associated with progressive 
disease can produce a variety of bioactive molecules that can directly affect the host. One 
microbial component, LPS, can activate macrophages and other cells to synthesize and 
secrete a wide array of molecules, including the cytokines IL-1b, TNF-a, IL-6, and PGE2 and 
matrix metalloproteinases. If they escape into the general circulation and cross the placental 
barrier, they could augment the physiologic levels of PGE2 and TNF-a in the amniotic fluid 
and induce premature labor. 
Human case-control studies have demonstrated that women who have low-birth-weight 
infants as a consequence of either preterm labor or premature rupture of membranes tend to 
have more severe periodontal disease than mothers with normal- birth-weight infants. In a 
recent case-control study, 48 case-control subjects had their gingival crevicular fluid (GCF) 
levels of PGE2 and IL-1b measured to determine whether mediator levels are related to 
current pregnancy outcome. In addition, the levels of four periodontal pathogens were 
measured by using microbespecific DNA probes. The results indicate that GCF PGE2 levels 
are significantly higher in mothers of preterm low-birthweight infants than in mothers of 
normal-birth-weight infants (controls). These data suggest a dose-response relationship for 
increased GCF PGE2 as a marker of current periodontal disease activity and decreasing 
birth weight. Four organisms associated with mature plaque and progressing periodontitis, 
Bacteroides forsythus, P. gingivalis, A. actinomycetemcomitans, and Treponema denticola, are 
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detected at higher levels in mothers of preterm low-birth-weight infants than in controls. 
These data suggest that biochemical measures of maternal periodontal status and oral 
microbial burden are associated with preterm birth and low birth weight. 18.2% of preterm 
low-birth-weight babies may result from periodontal disease— a previously unrecognized 
and clinically important risk factor for preterm birth and low birth weight. The association 
between periodontal disease and low birth weight may reflect the patient’s altered immune-
inflammatory trait that places the patient at risk for both conditions. 
Thus, periodontitis may be a marker for preterm delivery susceptibility as well as a potential 
risk factor. Indeed, the data from animal models suggest that even if periodontal disease is 
not the primary cause of prematurity, in a subset of patients it may serve as a contributor to 
the condition. Currently, there is insufficient evidence to link chronic periodontitis to 
specific adverse pregnancy outcomes. 
9. Cancer associated with chronic inflammation  
Various sudies confirmed that malignancies may arise from areas of infection and 
inflammation, simply as part of the normal host response. Indeed, there is a growing body 
of evidence that many malignancies are initiated by infections (Kuper et al., 2000; Sachter et 
al., 2002). Persistent infections within the host induce chronic inflammation. Leukocytes and 
other phagocytic cells induce DNA damage in proliferating cells, through their generation of 
reactive oxygen and nitrogen species that are produced normally by these cells to fight 
infection. These species react to form peroxynitrite, a mutagenic agent (Maeda &Akaike, 
1998). Hence, repeated tissue damage and regeneration of tissue, in the presence of highly 
reactive nitrogen and oxygen species released from inflammatory cells, interacts with DNA 
in proliferating epithelium resulting in permanent genomic alterations such as point 
mutations, deletions, or chromosomal rearrangements. 
More recently, a link between periodontal disease and cancer has been suggested. The 
scientific rationale behind the proposed association is that inflammation is a major factor in 
both periodontal disease and cancer.  
Oral cancer, gingival squamous cell carcinoma in particular, has been known to mimic 
advanced periodontal disease in clinical appearance showing similar symptoms of swelling, 
bleeding, tooth mobility, deep periodontal pockets, and bone destruction. Many cases have 
been reported of gingival squamous cell carcinoma presenting clinically similar to 
inflammatory periodontal or periodontal/endodontic lesions. Cases of other types of cancer 
mistaken for periodontal disease such as metastatic pancreatic cancer and osteogenic 
sarcoma have also been reported. These examples hint that a similar underlying mechanism 
may be responsible for both periodontal disease and cancer. 
9.1 Cancers and periodontal disease 
Several hypotheses are of interest in the potential etiology of a link between, periodontal 
disease and cancer. 
9.1.1 Alteration of the oral flora 
It has been suggested that carcinogenic metabolic by-products of periodontal disease might 
account for the relationship between the two diseases. When considering gastric cancers, it 
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had been argued that the mechanism of increased cancer risk may be an increased 
production of nitrosamines in situations of poor oral hygiene and that these by-products 
may function as gastro-intestinal organ specific carcinogens. Nitrosamines have been linked 
to cancers of the stomach and esophagus. Helicobacter pylori infection also plays a role in 
stomach cancers (Zarić et al, 2009). Other microorganisms have been studied as well as 
potential carcinogenic agents. There is also evidence that some strains of candidiasis have 
been seen at higher frequency in oral cancer patients. Viruses may also play a role. A 
suggestion has been made that increased periodontal disease may be associated with 
infection with cytomegalovirus and/or Epstein-Barr Virus 1 with mixed results. EBV of 
course has been linked to cancer including lymphoma and nasopharyngeal carcinoma. 
9.1.2 Increase in systemic circulatory inflammatory markers 
The presence of inflammatory cells and mediators such as chemokines, cytokines, and 
prostaglandins represent indicators associated with tumors. Also, the immune response 
mounted to a chronic periodontal infection has been proposed as a potential carcinogenic 
etiologic factor. Also of interest is the relationship between the pro-inflammatory 
expression of the receptor for advanced glycation end products (RAGE) and esophageal, 
gastric, colon, biliary, pancreatic, and prostate cancers. RAGE has been shown to play a 
role in the inflammatory processes of oral infections including periodontal disease. There 
are several obstacles in accurately determining a relationship between, periodontal 
disease and cancer.  
9.1.3 Confounding factors 
Smoking appeared to be the main confounding factor among these studies, especially for 
cancers strongly linked to tobacco use such as lung cancer. Other potential confounding 
factors are socio-economic status, diabetes, age, gender and ethnicity, along with 
genetics.  
9.2 Chronic periodontitis as a risk factor for pancreatic cancer 
Cancer of the pancreas is a rapidly fatal tumor. Smoking is the only well-documented 
modifiable risk factors for this cancer, although data suggest that diabetes, obesity and 
insulin resistance are also risk factors. Alcohol consumption is not an established risk factor 
for pancreatic cancer, but there is a strong association between alcohol consumption and 
chronic pancreatitis, and the latter has been associated with a higher risk for pancreatic 
cancer. 
Although viral infections have been strongly associated with cancers, several bacteria can 
promote or initiate abnormal cell growth by evading the immune system or suppressing 
apoptosis. Since periodontitis is a chronic oral bacterial infection, few authors have 
suggested a possible positive association between periodontitis and pancreatic cancer. 
Chronic periodontitis might promote pancreatic carcinogenesis, by means of systemic 
inflammation, or alternatively, through increased production of carcinogens, namely 
nitrosamines. Nitrosamines and gastric acidity have been suggested as factors that have an 
important role in pancreatic cancer, and tooth loss that occurs through poor dental hygiene 
may be a marker for more deleterious gastrointestinal flora and, consequently, greater 
endogenous nitrosation. In fact, endogenous formation of nitrosamines in the oral cavity in 
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individuals with poor oral hygiene is due to elevated levels of nitrate-reducing oral bacteria, 
including H. pylori. The association between H. pylori infection and pancreatic cancer was 
investigated, but this association could not be confirmed. 
A recent study has also suggested positive association between periodontitis and pancreatic 
cancer risk. Myeloperoxidase and superoxide dismutase help to regulate inflammation and 
are found to be elevated in periodontitis, and polymorphisms of these genes have been 
associated with elevated pancreatic cancer risk. 
10. Methods  
10.1 Patients 
Pancreatic tissue specimens were obtained from patients undergoing surgery for ANP (40) 
and for PC (20) at the Surgical Clinic of the Medical Center of Serbia. The research protocol 
received institutional evaluation and approval (Ethical Committee of the School of 
Dentistry, Belgrade). Periodontal evaluation was performed in the hospital, a day before 
planned surgical procedures, and included assessment of pocket depth (PD in mm) and 
clinical attachment loss (CAL in mm) at six points of every present tooth (mesio-buccal, 
mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual). The clinical parameters 
were evaluated with a periodontal probe (XP 23/UNC-15). All measurements were 
performed by a single periodontist (A.P.). Chronic periodontitis was defined by the 
presence of at least 4 non-adjacent teeth with sites CAL≥4mm and PD≥5mm (Okuda et al., 
2001). All patients that had been taking antibiotics in the previous three months and/or 
received periodontal treatment were excluded.  
12 pancreas specimens obtained during autopsies performed at the Institute of Pathology, 
School of Medicine, University of Belgrade were also included in the study and used as 
controls. The cause of death was not related to pancreas. 
Immediately after being taken, the specimens were frozen at -20 C until further 
processing. 
10.2 Bacterial DNA detection by PCR 
Tissue specimens were treated with proteinase K at 56°C for 30 minutes, followed by 10 
minutes of proteinase K inactivation at 95°C and 5 minutes centrifugation in a microfuge to 
pellet cell debris. 
The PCR was performed in volumes of 25 l containing PCR/Mg++ buffer, 0.2 mM of each 
dNTP, 0.2 M of each primer, 0.5 U Taq DNA polymerase and 3-5 l of template DNA 
containing supernatant. 
The amplification was performed in a DNA Thermal Cycler (Hybaid) programmed at 94°C 
(5 minutes) followed by 35 cycles at 94°C (1 min), annealing temperatures adequate for each 
primer pair (1 min) and extension at 72°C (1 minute 30 seconds) plus a final extension at 
72°C (5 min). The PCR amplified fragments were visualized in an 8% polyacrylamide gel 
stained with ethidium bromide, on an ultraviolet transilluminator.  
Peridontopathogens were detected by means of primer specific PCR. The list of primers, the 
annealing temperatures as well as the length of the products are given in Table 1. P. 
gingivalis and A. actinomycetemcomitans were amplified in the same multiplex PCR reaction, 
whilst T. Forshytia and P. Intermedia were coamplified in another multiplex reaction. E. 
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corrodens was amplified separately. Specimens of subgingival dental plaque, positive for 
those microorganisms were used as positive controls. For the negative control, DNA sample 
was omitted and replaced by water. 
 
Bacteria Primer pairs 
Annealing. 
t (C°) 
Amplicon
Size 
Porphyromonas 
gingivalis 
AGA GTT TGA TCC TGG CTC AG 
CAA TAC TCG TAT CGC CCG TTA TTC 
55 460 bp 
Aggregatibacter 
actinomycetemcomitans
AGA GTT TGA TCC TGG CTC AG 
CAC TTA AAG GTC CGC CTA CGT GC 
55 600 bp 
Tannerella forsythia 
AGA GTT TGA TCC TGG CTC AG 
GTA GAG CTT ACA CTA TAT CGC AAA CTC CTA
53 840 bp 
Prevotella intermedia
AGA GTT TGA TCC TGG CTC AG 
GTT GCG TGC ACT CAA GTC CGC C 
53 660 bp 
Eikenella corrodens 
CTA ATA CCG CAT ACG TCC TAA G 
CTA CTA AGC AAT CAA GTT GCC C 
53 800 bp 
Table 1. Primer sequences, annealing temperatures and size of obtained PCR products used 
for the detection of tested bacteria 
11. Results  
All 60 patients included in the study were diagnosed as chronic generalized periodontitis 
with a mean value of PD 3.12±0.35mm and CAL 2.79±0.82mm. 
A total of 72 specimens have been tested for the presence of 5 different 
periodontopathogens. The result was considered to be positive if a band of expected size 
was present on the gel. There was no attempt of sequencing the PCR products or 
quantifying the infectious agents by real-time PCR. 7 out of 40 specimens of acute 
necrotizing pancreatitis were positive for the presence of: E. corrodens (3 cases), A. 
actinomycetemcomitans (1 case), P. intermedia (1 case), T. forsythia (3 cases, Fig. 9), and T. 
forsythia and P. intermedia simultaneously (1 case). In one specimen of pancreatic cancer P. 
intermedia could be detected. Interestingly, two control specimens obtained from cadavers 
(cause of death was liver cirrhosis) harbored oral microorganisms. 
 
 
Fig. 9. Polyacrylamide gel electrophoresis showing bands that represent the product of PCR 
amplification corresponding to Tannerella forsythia 
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Data on tissue specimen origin and PCR findings are summarized in Table 2. 
 
Tissue no Pg Aa Pi Tf Ec 
ANP 40  1 2 2 3 
PC 20   1   
NP 12   1 1  
Table 2. The presence of periodontal pathogens in pancreatic tissue. ANP - acute necrotizing 
pancreatitis, PC - pancreatic cancer, NP - normal pancreatic tissue obtained post-mortem, Pg 
– Porphyromonas ginivalis, Aa – Aggregatibacter actinomycetemcomitans, Pi – Prevotella 
intermedia, Tf - Tannerella forsythia, Ec – Eikenella corroden 
12. Conclusion  
To the best of our knowledge, this is the first time that E. corrodens, A. actinomycetemcomitans, 
P. intermedia and B. forsythia have been described in ANP. Even though it is for some time 
obvious that periodontal pathogens can enter the circulation, causing transient bacteraemia, 
there were no systematic assessments of potential association between oral bacteria and 
extraoral infections. Although Eikenella species, for instance, have been shown to cause 
endocarditis and intraabdominal infection, they are considered a very rare etiological agent 
(Danzinger et al., 1994; Watkin et al., 2002). Interestingly, we found E. corrodens in three 
cases of acute necrotizing pancreatitis. Four other cases of ANP harbored other periodontal 
pathogens.  
Bacterial infections are usual complications in patients with acute pancreatitis but they 
typically include Salmonella, Campylobacter, Escherichia coli, Pseudomonas aeruginosa etc (Garg 
et al., 2001; Reimund et al., 2008). Generally, acute pancreatitis is not the primary 
manifestation of these infections. The presence of dental plaque bacteria in our cases of ANP 
does not exclude the simultaneous occurrence of other pathogens.  
Bacterial translocation which can be defined as the passage of intestinal microbes through 
the mucosa to internal organs is doubtlessly an important cause of pancreas infection. 
Nonetheless, other infection routes and infection sources should be considered as well, and 
the presence of periodontal microorganisms in ANP substantiates the hypothesis of 
alternative paths. Multiple risk factors of bacterial spreading, including surgery, tumour 
metastasis in the abdomen, compromising local anatomy and circulation, etc., are known to 
exist. Presumably, from abdominal aorta, where they can be found, oral bacteria are capable 
of reaching the main arteries supplying pancreas. Their presence in pancreatic tissue could 
be tentatively explained by compromised local circulation. The finding of bactDNA in two 
control pancreatic specimens, in which the cause of death was a non-pancreatic disease 
(cirrhosis), may be due to some contamination during autopsy. Infections in patients with 
cirrhosis are frequent and varied and their spreading in the peritoneum cannot be ruled out 
(Frances et al., 2008). In the present study, liver tissue has not been tested for the presence of 
periodontopathogens. 
The finding of only one case positive for P. intermedia in the pancreatic cancer group does 
not support the concept of direct oral bacteria involvement in the pathogenic processes, in 
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the same way as seen in atherosclerosis. On the other hand, pancreatic cancer has been 
previously related to different bacterial infections. Namely, Helicobacter DNA was detected 
in a very high percentage of pancreatic tumors and surrounding tissue (Nilson et al., 2006; 
Stolzenberg et at., 2001). As Helicobacter pylori is also frequently encountered in the oral 
cavity of individuals with periodontal disease (Souto et al., 2008, Zarić et al., 2009), its 
occurrence in the present cases of pancreatic cancer is very probable. A rising body of 
evidence supports the view on microbially induced and inflammation-driven malignancies 
(Engels et al., 2008; Lochhead&El-Omar, 2008; Michaud, 2007). 
Two large cohort studies looked at a link between pancreatic cancer and history of 
periodontal disease and found a significant association between the two (Michaud et al., 
2007, 2008). According to the authors periodontal disease might be a marker of a susceptible 
immune system or might directly affect cancer risk. Hujoel  found a significant association 
between pancreatic cancer and periodontitis measured by examination but again had a 
relatively small number of cases within their cohort. The results published by Michaud on 
increased incidence of pancreatic cancer among patients with periodontal disease could 
suggest a possible involvement of periodontopathogens in pancreatic cancer. Our study 
does not really confirm it, or at least does not point to direct, local contribution of oral 
microorganisms to the pathogenic process. Their role may be considered in terms of 
infection and chronic inflammation with systemic effect. 
The presence of periodontopathogens in various arteries, however, is an important finding. 
It means that oral microorganisms have theoretically the possibility to migrate to organs 
distant from their primary reservoir-the oral cavity, and invade them. Whether it will result 
in clinical or subclinical pathological changes remains uncertain. 
In periodontitis, periodontal pathogens and their products, as well as inflammatory 
mediators produced in periodontal tissues, might enter the bloodstream and contribute to 
the global inflammatory burden, causing systemic effects and/or contributing to systemic 
diseases. Several bacteria can promote or initiate abnormal cell growth by evading the 
immune system or suppressing apoptosis. Since periodontitis is a chronic oral bacterial 
infection, few authors have suggested a possible positive association between 
periodontitis and pancreatic cancer. To our knowledge, this is the first study which 
demonstrated the presence of periodontal bacteria in pancreatic tissue. Relatively low 
percentage of positive findings in our study does not represent a reliable proof of a link 
between periodontopathogens and pancreatic diseases. This might be explained by the 
fact that destruction of periodontal tissues in our study group was not extensive. Further 
researches to confirm association between periodontitis and pancreatic diseases are 
required. 
Epidemiological research (cross-sectional and longitudinal studies) can identify 
relationships but not causation. If some types of periodontal disease merely constitute an 
oral component of a systemic disorder or have etiological features in common with systemic 
diseases, periodontal and systemic diseases might frequently occur together without having 
a cause effect relationship (Slots, 1998). Medical community should be aware of the potential 
negative effects of periodontal infections on systemic health. First of all, periodontal 
infections must be recognized and treated, and then a regular oral care must be maintained. 
Nevertheless, with information accessible at the moment, it seems justified to state that good 
oral health is important to maintain good general health. 
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